Taro Pharmaceutical News and Activities

Taro Pharmaceutical is owned by Sun Pharma.

Sun Pharma is one of the...

• Forbes Global 2000 (#1073);
• Nifty 500;
• TOB Iconic 10,000.

Sun Pharma is a company listed under the stock ticker SUNPHARMA (IN).

Sun Pharma has a direct presence in 2 countries.

Sun Pharma has 4 subsidiaries including Chattem Chemicals, Natco Pharma and Sun Pharma USA.

They are in:

• Pharmaceuticals80%
• Chemicals20%

Acquisition, funding and merger involving Sun Pharma.

• Sun Pharma has acquired Taro Pharmaceutical (posted on June 25 2024).

View the org chart displaying its 19 main executives

Most searched biographies at Taro Pharmaceutical

• Uday Baldota, Chief Executive Officer and Director
• Erik Zwicker, Vice President, General Counsel and Secretary
• Avi Avramoff, Global Vice President Research & Development

Popular executive movements at Sun Pharma

• Andreas Eugen Busch has joined the company as Director  (posted on May 15 2026).
• Sagar Mahajan has joined the company as General Manager, Business Development  (posted on May 8 2026).
• Rama Bijapurkar, Independent Director, will leave the company on May 20, 2026  (posted on February 3 2026).

Click here to view some more movements at Sun Pharma

Create your alert
to follow the executive moves at Taro Pharmaceutical.

Sun Pharma has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Taro Pharmaceutical

• Taro Provides Results for the Quarter Ended June 30, 2022 | Taro Pharmaceutical
• Taro to Release First Quarter Results on July 27, 2022 | Taro Pharmaceutical
• Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2022 | Taro Pharmaceutical
• Taro Provides Results for the Year Ended March 31, 2022 | Taro Pharmaceutical
• News Releases | Taro Pharmaceutical
• Taro to Announce Full Year Results on May 26, 2022 | Taro Pharmaceutical
• Taro Completes Acquisition of Alchemee | Taro Pharmaceutical
• Taro to Acquire Alchemee From Galderma | Taro Pharmaceutical
• Taro Provides Results for December 31, 2021 | Taro Pharmaceutical
• Taro to Announce Third Quarter Results on January 27, 2022 | Taro Pharmaceutical
• View more press releases Close

Social media about Taro Pharmaceutical

• Taro Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Taro Pharmaceutical on LinkedIn, X (Twitter) & YouTube